Tech Company Financing Transactions
TB Biosciences Funding Round
TB Biosciences, based in Bethlehem, scored $1.5 million from Ben Franklin Technology Partners, NYU Innovation Fund and Originate Ventures.
Transaction Overview
Ben Franklin Technology Partners (Lead Investor) (Chad Paul)
NYU Innovation Fund (Lead Investor) (Frank Rimalovski)
Originate Ventures (Lead Investor) (Michael Gausling)
Company Information
Bethlehem, PA 18015
USA
Management Team
Browse more venture capital transactions:
Prev: 7/22/2013: Vamo venture capital transaction
Next: 7/22/2013: Livio Radio venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC transactions on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs